Trade Summary

5 days ago, Tahl Cindy, serving as See Remarks at Fate Therapeutics Inc (FATE), sold 25,590 shares at $1.88 per share, for a total transaction value of $48,084.00. Following this transaction, Tahl Cindy now holds 628,155 shares of FATE.

This sale represents a 4.00% decrease in Tahl Cindy's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, May 20, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 21, 2026 at 4:02 PM ET, 1 day after the trade was made.

Fate Therapeutics Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.